Management
FBDs should be managed with a biopsychosocial approach involving a multidisciplinary team to deliver holistic care that is patient-specific with the aim of ameliorating symptoms and improving quality of life. Patients should be informed of an FBD diagnosis early with a thorough explanation that FBDs are chronic, often relapsing conditions and are, therefore, incurable and hard to treat. Management strategies, therefore, do not have curative intent and instead focus on improving symptom control and reducing their impact on the sufferer’s daily life, as shown in table 6.
| BIOLOGICAL (MEDICAL) | |
| SYMPTOM | TREATMENT |
| Abdominal pain | 1st line: Antispasmodics – peppermint oil, hyoscine, mebeverine
2nd line: Antidepressants – Tricyclic antidepressants, selective serotonin reuptake inhibitors |
| Constipation | 1st line: Osmotic laxatives (macrogols – Movicol, Laxido)
2nd line: Prucalopride – 4 week trial in women with FBD who have failed treatment with 2 other laxatives 2nd line: Linaclotide – 3 month trial in patients with >1 year of constipation and no symptomatic improvement with maximum tolerated doses of previous laxatives |
| Diarrhoea | 1st line: Loperamide
2nd line: Ondansetron |
| PSYCHOLOGICAL | |
| THERAPY | Cognitive Behavioural Therapy
Gut-directed hypnotherapy Dynamic psychotherapy |
| SOCIAL (LIFESTYLE) | |
| LIFESTYLE CHANGES | Increased relaxation – optimising sleep hygiene, practising mindfulness
Regular physical activity (20 to 30 minutes 3-5 times per week) |
| DIETARY CHANGES | Increase:
Reduce:
Other advice:
|
Table 6: Management of FBDs
Take your subscriptions with you
Our mobile app allows you to access your interview and exam question banks wherever you are.